Abstract
Objective: Biokinetics, a profession registered with the Health Professions Council of South Africa (HPCSA), address inter alia chronic diseases of lifestyle (CDL) with exercise as treatment modality. The purpose of this investigation is to determine the potential market demand for biokinetic services in the private health care sector of South Africa. Methods: Data from a pharmaceutical benefit management system (PBM) were analysed to determine the prevalence of chronic diseases in the private health care sector for 2007. Telephonic interviews on a sub-sample of 50 biokineticists revealed the average number of patients that can be treated monthly per biokineticist. The number of biokineticists with active practice numbers was obtained from the Board of Health Care Funders (BHF). Results: The results indicate that 47% (747 199/1 600 000) of the patients managed by the PBM are treated with medication for one or more CDL. Non-steroid anti-inflammatory medication (21%), medication for cardiovascular diseases (13%) and bronchodilators (11%) had the highest prevalence. The sub-sample of biokineticists indicated that one biokineticist can treat an average of 100 patients per month. The potential market demand calculated from the above numbers indicated that 7 472 biokineticists are needed in the private health care sector, while only 625 active practice numbers were registered with the BHF in 2007.Conclusion: In conclusion, it is estimated that only 7.6% of patients with CDL can potentially be treated by the current number of registered biokineticists. Therefore an enormous market potential for biokinetics exists in the private health care sector of South Africa.
Highlights
In order to determine this potential demand the results will be presented by determining the prevalence of chronic diseases of lifestyle (CDL), reporting on the physical activity levels of the population and the available biokineticists and practices that address the CDL with exercise
The prevalence of CDL as represented by chronic medication use from a medicine claims database of a pharmaceutical benefit management system (PBM) company indicated that 911 212 chronic diseases were treated within the 1.6 million subscribers (Table I)
CDL are a reality in South Africa, a country with a double burden of disease that is created between CDL, known as non-communicable diseases, and the infectious diseases such as HIV/AIDS and tuberculosis, known as communicable diseases
Summary
Research methodology Data collectionThe study was an observational study to determine the potential market need for biokinetics. According to Wood[12] the market potential is all the customers who may be interested in the service that is presented. The approach that was followed (Fig. 1) was to determine the number of persons in the identified segment (persons with a chronic disease of lifestyle) that potentially require the service and the number of potential service delivery points (practising biokineticists) matching each other. This was performed within the South African private health care framework
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
